Gyeonggi-do, South Korea

Jin Ah Jeong

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 25.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Jin Ah Jeong: Advancements in GLP-1 Receptor Agonists

Introduction: Jin Ah Jeong is a notable inventor based in Gyeonggi-do, South Korea, recognized for his significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Jeong has focused on innovative compounds that hold promise for the treatment of metabolic diseases.

Latest Patents: Jin Ah Jeong’s recent patents include the development of novel compounds classified as GLP-1 receptor agonists. These compounds, along with their optical isomers and pharmaceutically acceptable salts, demonstrate remarkable activity as GLP-1 receptor agonists. Particularly, they enhance glucose tolerance, indicating their potential as therapeutic agents for metabolic diseases. Importantly, these compounds also show excellent pharmacological safety concerning cardiovascular systems, marking a significant advancement in pharmaceutical innovations.

Career Highlights: Jin Ah Jeong is associated with Il Dong Pharmaceutical Co., Ltd., a company that signifies progress in the pharmaceutical industry. Through his work, Jeong aims to innovate and improve treatment options available for patients suffering from metabolic disorders, thus enhancing quality of life and healthcare outcomes.

Collaborations: Throughout his career, he has collaborated with notable colleagues such as Hong Chul Yoon and Kyung Mi An. These collaborative efforts emphasize teamwork and the sharing of knowledge, which are crucial components in driving innovation and achieving successful breakthroughs in research and development.

Conclusion: As an inventor, Jin Ah Jeong’s contributions in developing GLP-1 receptor agonists illustrate the critical role of innovation in addressing health challenges. With ongoing research and collaboration, Jeong continues to pave the way for advancements in therapeutic strategies, particularly for metabolic diseases. His work at Il Dong Pharmaceutical Co., Ltd. reflects a commitment to fostering innovation in the pharmaceutical sector, ultimately benefiting patients and healthcare systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…